Case number 1:20-cv-00690
Novartis Pharma AG et al v. Regeneron Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 5, 2024 | 166 | STATUS REPORT (Joint) by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit(s) 1 - Federal Circuit Decision)(Cook, John) (Entered: 10/05/2024) (0) |
| Nov 7, 2022 | 163 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order regarding stay pending a decision on Novartis's appeal to the Federal Circuit by Regeneron Pharmaceuticals, Inc. submitted to Judge Hurd. (Cook, John) |
| Nov 7, 2022 | 164 | LETTER BRIEF (1) Docket Text: LETTER BRIEF by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. (McGuire, George) |
| Nov 7, 2022 | 165 | Order Staying Case (3) Docket Text: STIPULATION AND ORDER STAYING CASE: This Action shall be stayed pending a decision on Novartis appeal to the Federal Circuit. Parties are directed, as agreed, to file a joint status report within 10 days of the date on which the Federal Circuit issues a decision on or otherwise terminates Novartiss appeal. Signed by Magistrate Judge Christian F. Hummel on 11/7/2022. (tab) |
| Nov 1, 2022 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [160] Motion for Limited Admission Pro Hac Vice of Tom Yu, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 11/1/2022. (tab) |
| Oct 19, 2022 | N/A | Order (0) Docket Text: ORDER approving [154] Stipulation filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. regarding deadline extensions: [Close of Discovery: December 8, 2022; Opening Dispositive Motions :December 22, 2022; Responses to Dispositive Motions: January 17, 2023; Replies to Dispositive Motions: January 27, 2023]. Signed by Magistrate Judge Christian F. Hummel on 10/19/2022. (tab) |
| Oct 18, 2022 | N/A | Discovery Hearing (0) Docket Text: TEXT Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Discovery Hearing held on 10/18/2022 by TEAMS video. Appearances placed on the record by George R. McGuire, Esq. and William G. James, III, Esq. for plaintiff; Anish Desai, Esq.; Christopher Pepe, Esq. and John D. Cook, Esq. appearing for Defendant. Discovery issues are set forth and arguments are heard. Defendants request a briefing schedule on remaining issues and a schedule is set. Defendants are to file the Motion to Compel on or before 10/30/2022. Plaintiff's response is due by 11/11/2022; and any reply by 11/16/2022. (Court Reporter Jodi Hibbard)[10:00 am-10:31am] (tab) |
| Oct 18, 2022 | 156 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Regeneron Pharmaceuticals, Inc. for proceedings held on October 18, 2022 before Judge Hummel.. (Cook, John) |
| Oct 18, 2022 | 157 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC for proceedings held on 10/18/2022 before Judge Hummell.. (McGuire, George) |
| Oct 13, 2022 | 154 | Stipulation (4) Docket Text: STIPULATION and Proposed Order by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC submitted to Judge Christian F. Hummel. (McGuire, George) |
| Oct 7, 2022 | N/A | Order (0) Docket Text: TEXT ORDER re [152] Letter Motion from Defendant Regeneron Pharmaceuticals, Inc. requesting A pre-Motion filing Conference with the Court. Plaintiff is directed to file a response to Defendants Dkt.no.[152] by 10/14/2022. Plaintiff is permitted to file the response under seal, and the Court will accept the filing via email, with all counsel copied. A Discovery/Pre-Motion Hearing has been set for Tuesday, 10/18/2022 @ 10:00 AM. This conference will be conducted remotely, by Microsoft TEAMS video and the court will provide a TEAMS connection link to all participants, prior to the conference date. Authorized by Magistrate Judge Christian F. Hummel on 10/7/2022. (tab) |
| Aug 1, 2022 | 151 | Transcript (22) Docket Text: TRANSCRIPT of Proceedings: Discovery Hearing held on 7/27/2022 before Judge Christian F. Hummel, Court Reporter: Jacqueline Stroffolino, Telephone number: 518-257-1894. IMPORTANT NOTICE - REDACTION OF TRANSCRIPTS: In order to remove personal identifier data from the transcript, a party must electronically file a Notice of Intent to Request Redaction with the Clerk's Office within 5 business days of this date. The policy governing the redaction of personal information is located on the court website at www.nynd.uscourts.gov. Read this policy carefully. If no Notice of Intent to Redact is filed within 5 business days of this date, the court will assume redaction of personal identifiers is not necessary and the transcript will be made available on the web 90 days from today's date. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/22/2022. Redacted Transcript Deadline set for 9/1/2022. Release of Transcript Restriction set for 10/31/2022. Notice of Intent to Redact due by 8/8/2022 (jxs, ) |
| Jul 29, 2022 | 149 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Regeneron Pharmaceuticals, Inc. for proceedings held on July 27, 2022 before Judge Hummel.. (Cook, John) |
| Jul 29, 2022 | 150 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC for proceedings held on July 27, 2022 before Judge Hummel.. (McGuire, George) |
| Jul 27, 2022 | N/A | Discovery Hearing (0) Docket Text: TEXT Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Discovery Hearing held on 7/27/2022. Appearances by John Bennett, Esq. and William G. James, II, Esq. appearing in person, on behalf of the Plaintiff; Christopher Pepe, Esq. and John D. Cook, Esq. appearing in person and on behalf of Defendant. The discovery issues are set forth and addressed by the Court. After parties are heard on each issue, some resolution is agreed on and the parties are directed to reach out to the Court if issues still exist. The Court advises counsel that he will review the STIPULATION and [Proposed] Order Regarding Amendment of Invalidity Contentions, Dkt. no. 145 and STIPULATION MODIFYING CASE SCHEDULE, Dkt. no. 146 filed just prior to the conference, for approval. (Court Reporter Jacqueline Stroffolino)[11:02am-11:34am] (tab) |
| Jul 27, 2022 | 145 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Amendment of Invalidity Contentions by Regeneron Pharmaceuticals, Inc. submitted to Judge Hummel. (Cook, John) |
| Jul 27, 2022 | 146 | Stipulation (4) Docket Text: STIPULATION MODIFYING CASE SCHEDULE by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC submitted to Judge Christian F. Hummel. (McGuire, George) |
| Jul 27, 2022 | 147 | Order (2) Docket Text: ORDER approving [145] Stipulation and Order Regarding Amendment of Invalidity Contentions. Signed by Magistrate Judge Christian F. Hummel on 7/27/2022. (tab) |
| Jul 27, 2022 | 148 | Order (4) Docket Text: ORDER approving [146] Stipulation filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC, Modifying the Case Schedule. ( Discovery due by 12/2/2022, Dispositive Motions to be filed by 12/16/2022.) The case deadlines, as set forth in the Stipulation, are adopted and set. Signed by Magistrate Judge Christian F. Hummel on 7/27/2022. (tab) (Main Document 148 replaced on 7/27/2022) (tab, ). |
| Jul 19, 2022 | N/A | Notice (Other) (0) Docket Text: NOTICE of Dial-In Instructions: This case is scheduled for a Discovery Conference on 7/27/2022 @ 11:00 am. The Court is permitting dial-in, telephonic, participation for Counsel that are not participating in oral argument but would like to listen in on the hearing. Counsel are directed to dial in at 1-888-684-8852, enter Access code 9 7 7 2 7 1 9 #, and use Security code 1 2 3 4 # to join the hearing. Please be advised that counsel who intend to participate in oral argument during this hearing have been directed to appear in person. (tab) |
| Jul 12, 2022 | N/A | Notice of Hearing (0) Docket Text: COURT NOTICE of Change in Hearing (Date/Time): At the request of all parties, the Discovery Hearing has been reset for Wednesday, 7/27/2022 @ 11:00 AM in Albany before Magistrate Judge Christian F. Hummel. (tab) |
| Jul 11, 2022 | 140 | Order (5) Docket Text: ORDER approving [139] Stipulation filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC extending and resetting case deadlines, as set forth by the parties. Signed by Magistrate Judge Christian F. Hummel on 7/11/2022. (tab) |
| Jul 11, 2022 | N/A | Notice of Hearing (0) Docket Text: COURT NOTICE of Hearing: A Discovery Hearing [re: issues in resolving certain privilege issues] has been set for Thursday, 7/21/2022 @ 11:00 AM in Albany (in-person) before Magistrate Judge Christian F. Hummel. (tab) |
| Jul 7, 2022 | 139 | Stipulation (5) Docket Text: STIPULATION and Proposed Order Modifying Case Schedule by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC submitted to Judge Christian F. Hummel. (McGuire, George) |
| Jun 21, 2022 | 138 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Eric Shaun Hochstadt on behalf of Regeneron Pharmaceuticals, Inc. (Hochstadt, Eric) |
| Jun 10, 2022 | N/A | Order (0) Docket Text: TEXT ORDER re [135] Letter Motion from counsel for Regeneron Pharmaceuticals, Inc. requesting a Court conference to resolve certain privilege issues : Plaintiff is directed to file Response to Letter Brief [135] on or before 6/17/2022. Authorized by Magistrate Judge Christian F. Hummel on 6/10/2022. (tab) |
| Jun 8, 2022 | 133 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Regeneron Pharmaceuticals, Inc. for proceedings held on June 6, 2022 before Judge Hummel.. (Cook, John) |
| Jun 8, 2022 | 134 | Transcript (16) Docket Text: TRANSCRIPT of Proceedings: Discovery Hearing held on 6/6/2022 before Judge Christian F. Hummel, Court Reporter: Jacqueline Stroffolino, Telephone number: 5187429478. IMPORTANT NOTICE - REDACTION OF TRANSCRIPTS: In order to remove personal identifier data from the transcript, a party must electronically file a Notice of Intent to Request Redaction with the Clerk's Office within 5 business days of this date. The policy governing the redaction of personal information is located on the court website at www.nynd.uscourts.gov. Read this policy carefully. If no Notice of Intent to Redact is filed within 5 business days of this date, the court will assume redaction of personal identifiers is not necessary and the transcript will be made available on the web 90 days from today's date. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/29/2022. Redacted Transcript Deadline set for 7/11/2022. Release of Transcript Restriction set for 9/6/2022. Notice of Intent to Redact due by 6/13/2022 (jxs, ) |
| Jun 8, 2022 | 135 | Letter Request/Motion (20) Docket Text: Letter Motion from counsel for Regeneron Pharmaceuticals, Inc. requesting a Court conference to resolve certain privilege issues submitted to Judge Hummel . (Cook, John) |
| Jun 7, 2022 | N/A | Order (0) Docket Text: TEXT ORDER approving [131] Notice (Other) filed by Regeneron Pharmaceuticals, Inc., Attorney Robert T. Vlasis, III terminated. Authorized by Magistrate Judge Christian F. Hummel on 6/7/2022. (tab) |
| Jun 6, 2022 | N/A | Discovery Hearing (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Discovery Hearing held on 6/6/2022 by TEAMS video. Appearances by George R. McGuire, Esq. and John Bennett, Esq. for Plaintiffs; Christopher Pepe, Esq. and John Cook, Esq. for Defendants. Various issues regarding discovery are discussed with the Court and had, for the most part, been resolved by parties prior to the conference. Counsel raises an additional issue that may need to be briefed and the Court directs a letter brief be filed on that issue, if it is necessary. (Court Reporter Jacqueline Stroffolino)[11:00 am-11:20 am] (tab) |
| Jun 6, 2022 | 129 | Letter Request/Motion (1) Docket Text: Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Technology LLC, Novartis Technology LLC requesting withdrawal of Attorneys Molly Grammel and Calvin Wingfield submitted to Judge Hummel . (McGuire, George) |
| Jun 6, 2022 | N/A | Order on Letter Request (0) Docket Text: TEXT ORDER granting [129] Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Technology LLC, Novartis Technology LLC requesting withdrawal of Attorneys. [Attorneys Molly Grammel and Calvin Wingfield, terminated from case]. Authorized by Magistrate Judge Christian F. Hummel on 6/6/2022. (tab) |
| Jun 6, 2022 | 131 | Notice (Other) (3) Docket Text: NOTICE by Regeneron Pharmaceuticals, Inc. re [69] Notice of Appearance Withdrawal of Appearance and [Proposed] Order (Desai, Anish) |
| May 31, 2022 | N/A | Order on Letter Request (0) Docket Text: TEXT ORDER granting [126] Letter Motion from Regeneron Pharmaceuticals Inc. for Regeneron Pharmaceuticals, Inc. requesting a Conference with the Court: The Court directs Plaintiff to file a Response to Letter Motion [Dkt. no. 126] by 6/3/2022. A Discovery Hearing has been set for Monday, 6/6/2022 @ 11:00 AM. This conference will be conducted remotely, by Microsoft TEAMS video and the court will provide a TEAMS connection link to all participants, prior to the conference date.. Authorized by Magistrate Judge Christian F. Hummel on 5/31/2022. (tab) |
| May 18, 2022 | N/A | Order (0) Docket Text: TEXT ORDER approving [124] Stipulation filed by Regeneron Pharmaceuticals, Inc. regarding deadline extensions. Opening Expert Reports now Due July 7, 2022; Responsive Expert Reports Due August 4, 2022; Close of Discovery is reset to August 19, 2022; Dispositive Motions Due September 1, 2022; Response to Dispositive Motions Due September 21, 2022; Reply to Dispositive Motions Due September 29, 2022. [Discovery due by 8/19/2022, Motions to be filed by 9/1/2022]. Authorized by Magistrate Judge Christian F. Hummel on 5/18/2022. (tab) |
| May 12, 2022 | 124 | Stipulation (3) Docket Text: STIPULATION AND [PROPOSED] ORDER MODIFYING CASE SCHEDULE by Regeneron Pharmaceuticals, Inc. submitted to Judge Hummel. (Cook, John) |
| Mar 14, 2022 | 121 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by William G. James, II on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (James, William) |
| Mar 14, 2022 | 122 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by John Bennett on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (Bennett, John) |
| Mar 14, 2022 | 123 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Daniel P. Margolis on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (Margolis, Daniel) |
| Mar 7, 2022 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [119] Motion for Limited Admission Pro Hac Vice of John Bennett, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 3/7/2022. (tab) |
| Mar 2, 2022 | 118 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Elizabeth J. Holland on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (Holland, Elizabeth) |
| Feb 23, 2022 | N/A | Order (0) Docket Text: TEXT ORDER setting case deadlines. As was decided during the discovery/status conference held, by TEAMS video, on 2/18/2022, the following deadlines are set: The Advice of Counsel disclosure is due by 3/10/2022; Substantial completion of fact discovery to be completed by 5/6/2022; Opening expert reports due by 5/30/2022; Responsive expert reports due by 6/30/2022; Completion of all Discovery due by 7/15/2022; Dispositive Motions to be filed by 8/8/2022; Response due by 8/24/2022 and Reply due by 8/31/2022. Authorized by Magistrate Judge Christian F. Hummel on 2/23/2022. (tab) |
| Feb 18, 2022 | N/A | Discovery Hearing (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Discovery Hearing held on 2/18/2022 by TEAMS video. Appearances by George McGuire, Esq. and Elizabeth Holland, Esq. for Plaintiffs; Douglas Nash, Esq. and Anish Desai, Esq. and Christopher Pepe, Esq. for Defendants. (Many other counsel of record appearing on the TEAMS call but not entering an appearance for the record)After the court hears arguments from both sides as to the discovery schedule, the Court sets forth new case deadlines. A text Order setting the deadlines will be issued. (Court Reporter Jacqueline Stroffolino) (tab) |
| Feb 9, 2022 | N/A | Order on Letter Request (0) Docket Text: TEXT ORDER granting [114] Letter Motion from Douglas J. Nash for Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. requesting Scheduling Conference , and [115] Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Technology LLC, Novartis Technology LLC requesting Scheduling Conference: A Scheduling/Status Conference has been set for Friday, 2/18/2022 @ 10:00 AM. The conference will be conducted by Microsoft TEAMS video and a connection link for the conference will be provided by the court. Authorized by Magistrate Judge Christian F. Hummel on 2/9/2022. (tab) |
| Feb 4, 2022 | 114 | Letter Request/Motion (3) Docket Text: Letter Motion from Douglas J. Nash for Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. requesting Scheduling Conference submitted to Judge Hon. Christian F. Hummel . (Nash, Douglas) |
| Feb 4, 2022 | 115 | Letter Request/Motion (4) Docket Text: Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Technology LLC, Novartis Technology LLC requesting Scheduling Conference submitted to Judge Hon. Christian F. Hummel . (McGuire, George) |
| Feb 1, 2022 | 113 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Regeneron Pharmaceuticals, Inc. for proceedings held on November 5, 2021 before Judge Hummel.. (Cook, John) |
| Jan 31, 2022 | 112 | Order on Motion to Stay (43) Docket Text: MEMORANDUM_DECISION and ORDER denying [98] Motion to Stay; granting [103] Opening Claim Construction Brief. Regeneron Pharmaceuticals, Inc.s proposed claim construction is adopted in its entirety, and the Court affixes the meanings suggested by Regeneron Pharmaceuticals, Inc. to every disputed claim term; Regeneron Pharmaceuticals, Inc.s motion to stay proceedings in Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc., 1:20-CV-690 pending the Patent and Trademark Offices inter partes review of the validity of the 631 Patent is DENIED.IT IS SO ORDERED. Signed by Judge David N. Hurd on January 31, 2022. (gmd, ) Modified on 2/1/2022 to reflect the documents proper title(gmd, ). |
| Jan 21, 2022 | 109 | Responsive Claim Construction Brief (3) Docket Text: Responsive Claim Construction Brief by Regeneron Pharmaceuticals, Inc.. (Cook, John) |
| Jan 21, 2022 | 110 | Letter Request/Motion (3) Docket Text: Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting To File Portions of Brief Under Seal submitted to Judge Hurd . (McGuire, George) |
| Jan 20, 2022 | 108 | Transcript (17) Docket Text: TRANSCRIPT of Proceedings: FTR Pre-Motion Conference held on 11/5/2021 before Judge Christian F. Hummel, Court Reporter/Transcriber: Hannah Cavanaugh, Telephone number: 315-234-8545. IMPORTANT NOTICE - REDACTION OF TRANSCRIPTS: In order to remove personal identifier data from the transcript, a party must electronically file a Notice of Intent to Request Redaction with the Clerk's Office within 5 business days of this date. The policy governing the redaction of personal information is located on the court website at www.nynd.uscourts.gov. Read this policy carefully. If no Notice of Intent to Redact is filed within 5 business days of this date, the court will assume redaction of personal identifiers is not necessary and the transcript will be made available on the web 90 days from today's date. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 2/10/2022. Redacted Transcript Deadline set for 2/22/2022. Release of Transcript Restriction set for 4/20/2022. Notice of Intent to Redact due by 1/25/2022 (hfc, ) |
| Jan 19, 2022 | 107 | Transcript Request (2) Docket Text: TRANSCRIPT REQUEST by Novartis Pharma AG for proceedings held on November 5, 2021 before Judge Christian F. Hummel.. (McGuire, George) |
| Jan 6, 2022 | N/A | Order (0) Docket Text: TEXT ORDER approving [105] Notice of withdrawal of counsel filed by Regeneron Pharmaceuticals, Inc., Attorney Brian E. Ferguson terminated. Authorized by Magistrate Judge Christian F. Hummel on 1/6/2022. (tab) |
| Jan 5, 2022 | 105 | Notice (Other) (3) Docket Text: NOTICE by Regeneron Pharmaceuticals, Inc. re [33] Notice of Appearance Withdrawal of Appearance and [Proposed] Order (Cook, John) |
| Dec 28, 2021 | N/A | Clerk's Correction of Docket Entry (0) Docket Text: CLERK'S CORRECTION OF DOCKET ENTRY: Attorney Paul Cook contacted the Clerk's Office to advise that when the # [103] Opening Claim Construction Brief was uploaded, the image in the document cut off a portion of the text. Attorney Cook provided the Clerk's Office with a corrected version and the Clerk replaced the document. Service of docket number 103 will be regenerated. (pjh, ) |
| Dec 23, 2021 | 104 | Opening Claim Construction Brief (2) Docket Text: Opening Claim Construction Brief by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. Responsive Claim Brief due by 1/24/2022 (McGuire, George) |
| Nov 22, 2021 | N/A | Clerk's Correction of Docket Entry (0) Docket Text: CLERK'S CORRECTION OF DOCKET ENTRY re [101] Response in Opposition to Motion: Clerk replaced the main document to include the signature pages. (gmd, ) |
| Nov 5, 2021 | N/A | Pre-Motion Conference (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Pre-Motion Conference held on 11/5/2021. Appearances by George R. McGuire, Esq.; Elizabeth Holland, Esq. Ian Simmons, Esq. for Plaintiffs. Douglas Nash, Esq.; Anish Desai, Esq. for Defendants. Counsel are heard on the briefing schedule for the Motion to Stay, and their positions on the taking of depositions while the Stay motion is pending. The Court sets the following briefing schedule for Defendant's Motion to Stay: Motion to be filed on 11/5/2021; Response to be filed by 11/19/2021, and a Reply is due by 11/23/2021. Parties are directed to submit the motion as returnable before District Judge David N. Hurd. As to the taking of depositions, the Court orders that no depositions are to be taken while the Motion to Stay is pending. Parties are also directed to immediately meet and confer if the Motion to Stay is denied, in regard to scheduling the anticipated depositions. (Court Reporter FTR Recorded) (tab) |
| Nov 5, 2021 | N/A | Notice of Hearing on Motion (0) Docket Text: COURT NOTICE resetting Briefing Schedule for [98] MOTION to Stay filed by Regeneron Pharmaceuticals, Inc.: As was directed during the 11/5/2021 Telephone conference, Plaintiff's Response to Motion is due by 11/19/2021. And any Reply to Response to Motion due by 11/23/2021. The Motion is returnable before District Judge David N. Hurd and will be taken on submit unless otherwise directed. (tab) |
| Nov 4, 2021 | N/A | Order of Recusal (0) Docket Text: TEXT ORDER OF RECUSAL. The undersigned hereby RECUSES himself from this action. Having reviewed this matter more closely, it has come to my attention that I may have a conflict of interest, and therefore I recuse myself from this case. WHEREFORE, it is hereby ORDERED that the Clerk enter this Text Order of Recusal for the undersigned; and it is further ORDERED that the Clerk shall randomly reassign this case to another United States District Judge. (Chief Judge Glenn T. Suddaby recused. Case reassigned to District Judge David N. Hurd for all further proceedings. Magistrate Judge Christian F. Hummel remains the assigned magistrate judge in this action). SO ORDERED by Chief Judge Glenn T. Suddaby on 11/4/2021. (sal ) |
| Nov 4, 2021 | 96 | RESPONSE TO LETTER BRIEF (3) Docket Text: RESPONSE TO LETTER BRIEF filed by Regeneron Pharmaceuticals, Inc. as to [91] Letter Request/Motion, filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC . (Nash, Douglas) |
| Nov 2, 2021 | N/A | Order of Recusal (0) Docket Text: ORDER OF RECUSAL. Senior Judge Thomas J. McAvoy recused. Case reassigned to Chief Judge Glenn T. Suddaby for all further proceedings. Authorized by Senior Judge Thomas J. McAvoy on 11/2/2021. (amt) |
| Nov 2, 2021 | 91 | Letter Request/Motion (2) Docket Text: Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting a conference so that Regeneron can seek authorization for its stay motion submitted to Judge Christian F. Hummel . (McGuire, George) |
| Nov 2, 2021 | 92 | Letter Request/Motion (2) Docket Text: Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting SO ORDER Correction to respective Protective Order submitted to Judge Christian F. Hummel . (McGuire, George) |
| Nov 2, 2021 | 93 | Order on Letter Request (2) Docket Text: ORDER granting [92] Letter Motion from George R. McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting SO ORDER Correction to respective Protective Order submitted to Judge Christian F. Hummel [Order issued]. Signed by Magistrate Judge Christian F. Hummel on 11/2/2021. (tab) |
| Nov 2, 2021 | N/A | Notice of Hearing (0) Docket Text: COURT NOTICE of Hearing: A Telephone Hearing RE: Briefing Schedule on a Motion to Stay has been set for Friday, 11/5/2021 @ 10:00 AM in before Magistrate Judge Christian F. Hummel. The conference will be conducted by telephone and counsel are directed to dial in at 1-888-684-8852, enter access code 9772719# and security code 1234# to join the call.(tab) |
| Oct 28, 2021 | 89 | RESPONSE TO LETTER BRIEF (2) Docket Text: RESPONSE TO LETTER BRIEF filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC as to [88] Letter Request/Motion, filed by Regeneron Pharmaceuticals, Inc. . (McGuire, George) |
| Oct 7, 2021 | 87 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Matthew Sieger on behalf of Regeneron Pharmaceuticals, Inc. (Sieger, Matthew) |
| Sep 30, 2021 | 86 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Molly Grammel on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (Grammel, Molly) |
| Sep 17, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [84] Motion for Limited Admission Pro Hac Vice of Molly R. Grammel, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 9/17/2021. (tab) |
| Aug 30, 2021 | 83 | Answer to Counterclaim (4) Docket Text: ANSWER to [74] Answer to Amended Complaint, Counterclaim by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC.(McGuire, George) |
| Aug 24, 2021 | 82 | Uniform Pretrial Scheduling Order (19) Docket Text: UNIFORM PRETRIAL SCHEDULING ORDER with Attachment A- Patent Schedule: Anticipated length of trial: to be determined. Preferred Trial Location: Albany, NY. Joinder of Parties due by 9/15/2021. Amended Pleadings due by 9/15/2021. Signed by Magistrate Judge Christian F. Hummel on 8/24/2021. (tab) |
| Aug 23, 2021 | 81 | Transcript (19) Docket Text: TRANSCRIPT of Proceedings: Rule 16 Conference held on 8/18/2021 before Judge Christian F. Hummel, Court Reporter: Jacqueline Stroffolino, Telephone number: 518-257-1894. IMPORTANT NOTICE - REDACTION OF TRANSCRIPTS: In order to remove personal identifier data from the transcript, a party must electronically file a Notice of Intent to Request Redaction with the Clerk's Office within 5 business days of this date. The policy governing the redaction of personal information is located on the court website at www.nynd.uscourts.gov. Read this policy carefully. If no Notice of Intent to Redact is filed within 5 business days of this date, the court will assume redaction of personal identifiers is not necessary and the transcript will be made available on the web 90 days from today's date. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/13/2021. Redacted Transcript Deadline set for 9/23/2021. Release of Transcript Restriction set for 11/22/2021. Notice of Intent to Redact due by 8/30/2021 (jxs, ) |
| Aug 20, 2021 | 80 | Protective Order (25) Docket Text: AMENDED STIPULATED PROTECTIVE ORDER {so ordered}. Signed by Magistrate Judge Christian F. Hummel on 8/20/2021. (tab) |
| Aug 19, 2021 | 76 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC for proceedings held on 08/18/2021 before Judge Christian F. Hummel.. (McGuire, George) |
| Aug 19, 2021 | 77 | Stipulation (25) Docket Text: STIPULATION [PROPOSED] AMENDED STIPULATED PROTECTIVE ORDER by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC submitted to Judge Hon. Christian Hummel. (McGuire, George) |
| Aug 19, 2021 | N/A | Order Removing Case from ADR (0) Docket Text: TEXT ORDER: The Court held a Rule 16 Initial Conference with the parties on 8/18/2021. The Court, sua sponte, exempts this matter from the Mandatory Mediation Program. SO ORDERED. Authorized by Magistrate Judge Christian F. Hummel on 8/19/2021. (tab) |
| Aug 19, 2021 | 79 | Transcript Request (3) Docket Text: TRANSCRIPT REQUEST by Regeneron Pharmaceuticals, Inc. for proceedings held on August 18, 2021 before Judge Hummel.. (Cook, John) |
| Aug 18, 2021 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Initial Pretrial Conference held on 8/18/2021. Appearances by George R. McQuire, Esq. Elizabeth Holland, Esq. and Molly Grammel, Esq. for Plaintiff; Douglas Nash, Esq. and Anish Desai, Esq. for Defendants. The Court hears arguments from counsel on the deadline proposals that are not in agreement and makes his rulings. A Scheduling Order will be issued. (Court Reporter Jacqueline Stroffolino) (tab) |
| Aug 16, 2021 | 74 | Answer to Amended Complaint (30) Docket Text: ANSWER to [70] Amended Complaint, (Redacted), COUNTERCLAIM against Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC by Regeneron Pharmaceuticals, Inc..(Cook, John) |
| Aug 3, 2021 | N/A | Set/Reset Answer Deadline (0) Docket Text: ***Answer due date updated for Regeneron Pharmaceuticals, Inc. answer due 8/16/2020. (gmd) |
| Aug 3, 2021 | N/A | Order on Motion to Dismiss for Failure to State a Claim (0) Docket Text: TEXT ORDER terminating as moot Defendant's [54] Motion to Dismiss for Failure to State a Claim. Authorized by Senior Judge Thomas J. McAvoy on 8/3/2021. (amt) |
| Aug 2, 2021 | 70 | Amended Complaint* (1) |
| Aug 2, 2021 | 70 | Amended Complaint (12) Docket Text: AMENDED COMPLAINT AND ANSWER TO COUNTERCLAIM against Novartis Technology LLC, Novartis Pharma AG, Novartis Pharmaceuticals Corporation filed by Novartis Technology LLC, Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(McGuire, George) |
| Aug 2, 2021 | 71 | Notice (Other) (2) Docket Text: NOTICE by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC re [54] MOTION to Dismiss for Failure to State a Claim (Partial) filed by Regeneron Pharmaceuticals, Inc.. Motion returnable before Judge McAvoy (McGuire, George) |
| Jul 29, 2021 | 68 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Christopher Pepe on behalf of Regeneron Pharmaceuticals, Inc. (Pepe, Christopher) |
| Jul 29, 2021 | 69 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Robert T. Vlasis, III on behalf of Regeneron Pharmaceuticals, Inc. (Vlasis, Robert) |
| Jul 26, 2021 | 67 | Notice (Other) (1) Docket Text: NOTICE by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC re [54] MOTION to Dismiss for Failure to State a Claim (Partial) filed by Regeneron Pharmaceuticals, Inc.. Motion returnable before Judge McAvoy (McGuire, George) |
| Jul 22, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [59] Motion for Limited Admission Pro Hac Vice of Petra Scamborova, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/22/2021. (tab) |
| Jul 22, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [60] Motion for Limited Admission Pro Hac Vice for James T. Evans, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/22/2021. (tab) |
| Jul 16, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [56] Motion for Limited Admission Pro Hac Vice of Andrew P. Gesior, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/16/2021. (tab) |
| Jul 16, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [57] Motion for Limited Admission Pro Hac Vice of Priyata Y. Patel, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/16/2021. (tab) |
| Jul 16, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [58] Motion for Limited Admission Pro Hac Vice of Matthew D. Sieger, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/16/2021. (tab) |
| Jul 11, 2021 | 55 | Answer to Complaint (30) Docket Text: PARTIAL ANSWER to [1] Complaint, (Redacted), COUNTERCLAIM against Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC by Regeneron Pharmaceuticals, Inc..(Cook, John) |
| Jul 9, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [46] Motion for Limited Admission Pro Hac Vice of Natalie C. Kennedy, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/9/2021. (tab) |
| Jul 9, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [47] Motion for Limited Admission Pro Hac Vice of Larry A. Coury, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/9/2021. (tab) |
| Jul 9, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [48] Motion for Limited Admission Pro Hac Vice of Robert T. Vlasis, III, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/9/2021. (tab) |
| Jul 9, 2021 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [49] Motion for Limited Admission Pro Hac Vice of Christopher Pepe, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 7/9/2021. (tab) |
| Jun 22, 2021 | N/A | Notice of Hearing (0) Docket Text: COURT NOTICE of Conference: The Initial Conference has been set for Wednesday, 8/18/2021 @ 10:30 AM in Albany before Magistrate Judge Christian F. Hummel. The Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 8/11/2021. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) Counsel have the option of participating in person or by telephone and are directed to notify your adversary as to how you plan to participate. Counsel opting to dial in are directed to dial in at 1-888-684-8852, enter access code 9772719# and use security code 1234# to join the call.(tab) |
| Jun 18, 2021 | 43 | Notice (Other) (1) Docket Text: NOTICE by Regeneron Pharmaceuticals, Inc. re Status Conference,, Proposed Dates for Rule 16 Conference (Nash, Douglas) |
| Jun 18, 2021 | 44 | Notice (Other) (2) Docket Text: NOTICE by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC re: Status Conference (McGuire, George) |
| Jun 11, 2021 | N/A | Status Conference (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Christian F. Hummel: Status Conference held on 6/11/2021. Appearances by George McGuire, Esq. and Elizabeth Holland, Esq. for Plaintiffs; Douglas Nash, Esq., Brian Ferguson, Esq., Elizabeth Weiswasser, Esq., John D. Cook, Esq., appearing for the defendants. Parties set forth their positions regarding the lifting of the current stay. The Court lifts the Stay and directs that Defendants file their answer. The Answer deadline is set for 7/11/2021. The Civil Case Management Plan is directed to be filed by 8/9/2021. Parties are to file letters with the Court by 6/18/2021 regarding a date proposed for the Rule 16 conference. (tab) |
| Jun 7, 2021 | N/A | Order on Letter Request (0) Docket Text: TEXT ORDER granting [41] Letter Request from George McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting a Court Conference. A Status Conference has been set for Friday, 6/11/2021 @ 10:00 AM. The conference will be held by telephone and Counsel are directed to dial in @ 1-888-684-8852, enter access code 9772719# and use security code 1234# to join the call. Authorized by Magistrate Judge Christian F. Hummel on 6/7/2021. (tab) |
| Jun 3, 2021 | 41 | Letter Request/Motion (2) Docket Text: Letter Motion from George McGuire for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC requesting a Court Conference submitted to Judge Hon. Christian F. Hummel . (McGuire, George) |
| May 4, 2021 | 39 | Status Report (2) Docket Text: STATUS REPORT by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. (McGuire, George) |
| May 4, 2021 | 40 | Status Report (2) Docket Text: STATUS REPORT by Regeneron Pharmaceuticals, Inc.. (Nash, Douglas) |
| Apr 12, 2021 | 35 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Douglas J. Nash on behalf of Regeneron Pharmaceuticals, Inc. (Nash, Douglas) |
| Apr 12, 2021 | 36 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by John D. Cook on behalf of Regeneron Pharmaceuticals, Inc. (Cook, John) |
| Apr 9, 2021 | 33 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brian E. Ferguson on behalf of Regeneron Pharmaceuticals, Inc. (Ferguson, Brian) |
| Apr 9, 2021 | 34 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Elizabeth Weiswasser on behalf of Regeneron Pharmaceuticals, Inc. (Weiswasser, Elizabeth) |
| Apr 8, 2021 | 31 | Status Report (2) Docket Text: STATUS REPORT by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. (McGuire, George) |
| Apr 8, 2021 | N/A | Order (0) Docket Text: TEXT ORDER re [31] Status Report filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. Defendants are directed to file a response to Dkt. No. [31] Status Report by 4/16/2021. Authorized by Magistrate Judge Christian F. Hummel on 4/8/2021. (tab) |
| Feb 4, 2021 | N/A | Status Report Order (0) Docket Text: STATUS REPORT ORDER: Status Report due by 5/4/2021. Authorized by Magistrate Judge Christian F. Hummel on 2/4/2021. (tab) |
| Feb 3, 2021 | 29 | Status Report (4) Docket Text: STATUS REPORT Joint by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. (McGuire, George) |
| Nov 3, 2020 | N/A | Status Report Order (0) Docket Text: TEXT STATUS REPORT ORDER: Status Report due by 2/3/2021. Authorized by Magistrate Judge Christian F. Hummel on 11/3/2020. (tab) |
| Oct 30, 2020 | 27 | Status Report (3) Docket Text: STATUS REPORT Joint Status Report in connection with stay by Novartis Pharma AG. (McGuire, George) |
| Jul 30, 2020 | N/A | Set Deadlines/Hearings (0) Docket Text: Set Deadlines: Status Report due by 10/30/2020. (tab) |
| Jul 30, 2020 | N/A | Order on Motion to Stay (0) Docket Text: TEXT ORDER granting [24] Motion to Stay the case. The case is STAYED. Parties are directed to file a status report in 90 days regarding the status of the investigation by the U.S. International Trade Commission. (Status Report due by 10/30/2020). Authorized by Magistrate Judge Christian F. Hummel on 7/30/2020. (tab) |
| Jul 30, 2020 | N/A | Notice (Other) (0) Docket Text: TEXT NOTICE: The Rule 16 Initial Conference scheduled for 9/22/2020 at 10:00 AM before Magistrate Judge Christian F. Hummel and the deadline to submit a proposed Civil Case Management Plan and exchange Mandatory Disclosures are ADJOURNED without date while this case is STAYED. The Initial Conference will be rescheduled at the appropriate time. (tab) |
| Jul 16, 2020 | N/A | Order (0) Docket Text: TEXT ORDER approving [22] Notice (Other) filed by Regeneron Pharmaceuticals, Inc. Answer due date updated for Regeneron Pharmaceuticals, Inc. answer due 8/5/2020. Authorized by Magistrate Judge Christian F. Hummel on 7/16/2020. (tab) |
| Jul 15, 2020 | 22 | Notice (Other) (3) Docket Text: NOTICE by Regeneron Pharmaceuticals, Inc. re [1] Complaint, Stipulation to Extend Time to Answer (Desai, Anish) |
| Jul 14, 2020 | 21 | Affidavit of Service (1) Docket Text: AFFIDAVIT of Service for Summons and Complaint, Civil Cover Sheet and General Order #25 served on Sue Zouky / Secretary of State on 6/24/20, filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC. (McGuire, George) |
| Jul 7, 2020 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [13] Motion for Limited Admission Pro Hac Vice of Joshua S. Weinger, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Signed by Magistrate Judge Christian F. Hummel on 7/7/2020. (tab) |
| Jul 7, 2020 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [14] Motion for Limited Admission Pro Hac Vice of Linnea P. Cipriano, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Signed by Magistrate Judge Christian F. Hummel on 7/7/2020. (tab) |
| Jul 7, 2020 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [15] Motion for Limited Admission Pro Hac Vice for Myomi T. Coad, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Signed by Magistrate Judge Christian F. Hummel on 7/7/2020. (tab) |
| Jul 7, 2020 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [16] Motion for Limited Admission Pro Hac Vice for William G. James, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Signed by Magistrate Judge Christian F. Hummel on 7/7/2020. (tab) |
| Jun 26, 2020 | N/A | Order on Motion for Limited Admission Pro Hac Vice (0) Docket Text: TEXT ORDER granting [10] Motion for Limited Admission Pro Hac Vice of Elizabeth Jean Holland, Esq. Counsel is hereby advised that as of January 16, 2018, the NYND has converted to NextGen. Due to this conversion, you must now register for Pro Hac Vice access through your PACER account. This is the only notice you will receive concerning this requirement. You will not have access to electronically file in this case until your Pro Hac Vice request has been processed through the PACER system. Step-by-step instructions on how to complete this process are available at http://www.nynd.uscourts.gov/attorney-admissions-nextgen. Authorized by Magistrate Judge Christian F. Hummel on 6/26/2020. (tab) |
| Jun 26, 2020 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Calvin E. Wingfield on behalf of Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC (Wingfield, Calvin) |
| Jun 22, 2020 | 2 | G.O. 25 Filing Order (16) Docket Text: G.O. 25 FILING ORDER ISSUED: Initial Conference set for 9/22/2020 10:00 AM in Albany before Magistrate Judge Christian F. Hummel. Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 9/15/2020. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) (dpk) |
| Jun 22, 2020 | 3 | Summons Issued (2) Docket Text: Summons Issued as to Regeneron Pharmaceuticals, Inc. (dpk) |
| Jun 22, 2020 | 4 | Report on the Filing and Determination of an Action regarding a Patent or Trademark sent to USPTO (1) Docket Text: Report on the Filing and Determination of an Action regarding patent and/or trademark number(s) 9,220,631. (dpk) |
| Jun 22, 2020 | 5 | Notice of Admission Requirement (1) Docket Text: NOTICE of Admission Requirement as to Party Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC; Attorney Josh Weinger, Esq. admissions due by 7/6/2020. (dpk) |
| Jun 22, 2020 | 6 | Notice of Admission Requirement (1) Docket Text: NOTICE of Admission Requirement as to Party Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC; Attorney William James, Esq. admissions due by 7/6/2020. (dpk) |
| Jun 22, 2020 | 7 | Notice of Admission Requirement (1) Docket Text: NOTICE of Admission Requirement as to Party Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC; Attorney Myomi Coad, Esq. admissions due by 7/6/2020. (dpk) |
| Jun 22, 2020 | 8 | Notice of Admission Requirement (1) Docket Text: NOTICE of Admission Requirement as to Party Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC; Attorney Elizabeth Holland, Esq. admissions due by 7/6/2020. (dpk) |
| Jun 22, 2020 | 9 | Notice of Admission Requirement (1) Docket Text: NOTICE of Admission Requirement as to Party Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Attorney Linnea Cipriano, Esq. admissions due by 7/6/2020. (dpk) |
| Jun 19, 2020 | 1 | Complaint* (1) |
